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In randomised controlled trials that have non-compliance
with the treatment assigned, policy makers require
unbiased estimates of the causal effect of the treatment
received. Instrumental variable (IV) approaches provide
complier average causal effects (CACE) estimates.
Common IV methods such as two-stage least squares
(2SLS) have not been extended to settings with multivari-
ate outcomes.
We propose a three-stage least squares (3SLS) regres-
sion approach, whereby estimates from the first stage
regression of treatment received conditional on assign-
ment, feed into a seemingly unrelated regression (SUR)
system of equations that recognise the correlation between
the outcomes. We also develop Bayesian IV approaches
which jointly model the effects of random assignment on
treatment received, and the bivariate outcome, which here
is assume to be cost-effectiveness. We also apply 2SLS
individually to each outcome, for comparison.
We consider the performance of these methods in a
simulation study, where costs are assumed to follow
Normal or Gamma distributions, to have positive and
negative correlation with health outcomes, the instrument
is strong (30% non-compliance) or weak (70% non-
compliance), and the sample size, moderate (n=1,000) or
small (n=100). We find that the proposed IV methods
generally perform well. For example, in scenarios with
Normally distributed cost data and a strong instrument,
each method reports unbiased estimates. However, in
these settings the 2SLS approach reports levels of
Confidence Interval (CI) coverage that are above (positive
correlation) and below (negative correlation) nominal
levels. By contrast both the 3SLS and Bayesian methods
report CI coverage close to nominal levels.
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